Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Maximize your weekends with these quick money-making ideas. Discover ways to earn extra cash without a long-term commitment.
19,179 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
President Trump announces a new tariff package under a different statute, prompting questions about legality and mark...
Bitcoin and Ethereum lead a broad crypto rebound as on-chain data shows heavy whale buying. XRP and major altcoins ra...
Block announces a sweeping AI-driven layoff, cutting roughly 4,000 jobs and shrinking headcount to under 6,000. The m...
A surge of XRP tokens—roughly 472 million coins worth about $650 million—was sent to Binance, heightening bets on nea...
A quick surge in a mining stock can spark headlines and questions. This guide breaks down the what, why, and how to r...
Geopolitical tensions are lifting oil prices and sending oil stocks higher. But is this trend sustainable or a tempor...
Forecasting Tesla is never dull. This article lays out base, bull, and bear scenarios for the next five years, with a...
Vitalik Buterin unveiled a three-part framework for Ethereum, aiming to reshape the network’s use case and potentiall...
IREN is positioning itself as a key AI infrastructure partner as demand for GPU compute grows. This article explores ...
Mosaic’s rare earths could become a new growth engine as the company partners with Rainbow Rare Earths to recover NdP...
Three global e-commerce leaders are trading at bargain prices as reinvestment cycles press on near‑term earnings, pot...